28

nanotimes

Companies Facts

Investor Relations & Corporate Communications, will support both the upcoming product launch of the company‘s EU approved therapy for the treatment of brain tumors and the further development of its Nano-Cancer®

tions. MagForce expects its Nano-Cancer®

therapy in additional cancer indica- therapy

will become available at several leading German cancer centers in the first quarter of 2011.

Dr. Christoph Rehfuess joins MagForce as Director of Intellectual Property; Dr. Dirk Kautz joins MagForce as Director of Business/Corporate Development and will support the Management Board in strategic planning; Kajo Wiest joins as Director of Finance & Controlling and brings with him more than 10 years of finance and controlling experience at Jerini AG; Stacy Wiedenmann joins the company as Director of Investor Relations & Corporate Communications.

Furthermore, MagForce has been selected as the 2010 recipient of the STEP award in the category product/technology. The business award, initiated by Infraserv Höchst and F.A.Z. Institute, both Germany, along with leading industry sponsors, was awarded for the fifth time this year. http://www.magforce.com

T sec

he Motorola Solutions business of Motorola, Inc. (NYSE: MOT) has entered into an agree-

ment with Kopin Corporation (NASDAQ: KOPN) to develop a hands-free computer and communications headset. This new device category is a head-worn, mobile computer headset with full voice, audio and PC capabilities, leveraging Kopin‘s advanced system and micro-display technologies to create a virtual 15-inch monitor that supports simulation software, streaming video on-demand and other large-screen

Typical measurement system: >180 sec µsprint: 1 sec

10-10/11 :: October/November 2010

Advertisement

Too fast for a photo: the new µsprint

NanoFocus AG Lindnerstrasse 98 | 46149 Oberhausen Phone +49 (0) 208-62 000-0 | Fax +49 (0) 208-62 000 info@nanofocus.de | www.nanofocus.de WKN: 540066 | ISIN: DE 0005400667

NF10030